Background illustration for clinical trials search

Paid Clinical Trials Stamford

Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: New York NY, New Haven CT, Totowa NJ, Foxborough MA,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: New York NY, Albany NY, Philadelphia PA, Wilmington DE,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: New York NY, Farmington CT, Raleigh NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07217587

Phase3, Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL),
Location: New York NY, New Haven CT, New Brunswick NJ, Montreal,
Sponsor: Arvinas Inc.

Sex: All

Age: 18+

Code: NCT06393738

Phase1, Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Derby CT, New Haven CT, North Haven CT, Guilford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06465316

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Derby CT, New Haven CT, Guilford CT, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase2, Recruiting

Daily Inclusion of Eggs in a Heart-Healthful Dietary Pattern in Hyperlipidemic Adults

for
Hyperlipidemias
Location: Derby CT
Sponsor: Griffin Hospital

Sex: All

Age: 18+

Code: NCT05807334

Recruiting

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

for
Psychosis Associated With Alzheimer's Disease
Location: Woodmere NY, Farmington CT, Matthews NC, Atlanta GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT05980949

Phase3, Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

for
Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis,
Location: Ridgewood NY, Orange CT, Cheektowaga NY, Toledo OH,
Sponsor: Alebund Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06933472

Phase3, Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

for
Amblyopia
Location: New York NY, New Haven CT, Philadelphia PA, Boston MA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4 - 7

Code: NCT06380517

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

for
Major Depressive Disorder (MDD),
Location: Cedarhurst NY, New York NY, Brooklyn NY,
Sponsor: Seaport Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07065240

Phase2, Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for
SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors,
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07129252

Phase1, Phase2, Recruiting

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New York NY, Sarasota FL, Houston TX, New Haven CT,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06998407

Phase1, Phase2, Recruiting

RevCore for In Stent Thrombosis

for
In-stent Thrombosis
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT06394739

Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: New York NY, New Haven CT, Boston MA, Fairfax VA,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase1, Phase2, Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

for
Ulcerative Colitis, Crohn Disease
Location: New York NY, New Haven CT, Providence RI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05230173

Recruiting

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

for
Intracranial Meningioma
Location: New York NY, New Haven CT, Boston MA, Durham NC,
Sponsor: RTOG Foundation, Inc.

Sex: All

Age: 18+

Code: NCT06955169

Phase2, Recruiting

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: New York NY, New Haven CT, Durham NC, Charleston SC,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07098988

Phase2, Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: New York NY, New Haven CT, New Brunswick NJ,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase2, Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

for
Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Location: New York NY, New Haven CT, Chapel Hill NC, Milwaukee WI,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT06656494

Phase1, Recruiting